Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

HISTORICAL FACTS: 9 - Caught on Camera

Moderna CEO Says Melanoma Vaccine Could Be Available By 2025

Moderna CEO Stephane Bancel told AFP his company's experimental vaccine against melanoma could be available in as little as two years, in what would amount to a landmark step against the most serious form of skin cancer.

International Business Times

Customizing mRNA is easy, and that's what makes it the next frontier for personalized medicine − a molecular biologist explains

While using mRNA as medicine is new, mRNA has been inside you for your entire life. The cells in your body create mRNAs that serve as instructions to make specific proteins you need to function. Researchers can create new mRNAs to correct those instructions when they aren’t working.

The Conversation

Should You Invest In IPOs? It's Still A Risky Prospect

Investing in IPOs may sound exciting, but it's often better to wait for newly public stocks to mature before buying.

Kiplinger

From analysis to the latest developments in health,
read the most diverse news in one place.

What are the new COVID booster vaccines? Can I get one? Do they work? Are they safe?

As the COVID virus continues to evolve, so does our vaccine response. From December 11, Australians will have access to new vaccines that offer better protection.

The Conversation

Moderna’s CFO on the $25 billion innovation plan to work past the post-COVID slump

“There’s a true organic growth opportunity here,” Jamey Mock says.

Fortune

Why is Covid-19 Still Affecting the Healthcare Industry?

Back in May, the World Health Organization declared an end to the global Public Health Emergency for Covid-19. Despite the end of the pandemic, however, the healthcare industry is still feeling its effects. Vaccine makers and pharmacy chains are seeing a steep decline in the number of people getting Covid...

Barchart

Beyond COVID vaccines: what else could mRNA technology do for our health?

Many people first became familiar with the term “mRNA” when Pfizer’s and Moderna’s COVID vaccines were rolled out. In the simplest terms, mRNA, which stands for messenger ribonucleic acid, is a type of genetic material that gives cells in our bodies instructions to make specific proteins.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

Flu-COVID combo vaccines on the horizon

Moderna announces plans to move a novel vaccine design into its final stage of development

Salon

Novavax COVID-19 vaccine approved

Vaccine uses different technology than Moderna and Pfizer's mRNA targeting strategy

Salon

US adds another option for fall COVID vaccination with updated Novavax shots

U.S. regulators have added another option for fall COVID-19 vaccination, updated shots made by Novavax

The Independent UK

The trouble with a Nobel for mRNA COVID vaccines

The mRNA vaccine story during the COVID-19 pandemic placed an extraordinary premium on altruism on the part of scientists

The Hindu

Tenacious curiosity in the lab can lead to a Nobel Prize – mRNA research exemplifies the unpredictable value of basic scientific research

The 2023 Nobel Prize in physiology or medicine will go to Katalin Karikó and Drew Weissman for their discovery that modifying mRNA – a form of genetic material your body uses to produce proteins – could reduce unwanted inflammatory responses and allow it to be delivered into cells. While the…

The Conversation

Years of research laid the groundwork for speedy COVID-19 shots

The Nobel Prize in Medicine has been awarded to two scientists whose work led to mRNA vaccines against COVID-19

The Independent UK

Nobel prize in medicine awarded to mRNA pioneers – here's how their discovery was integral to COVID vaccine development

Billions of people around the world have received the Pfizer or Moderna COVID-19 vaccines. The rapid development of these vaccines changed the course of the pandemic, providing protection against the SARS-CoV-2 virus.

The Conversation

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu

Katalin Kariko, scientific maverick who paved way for mRNA vaccines

Katalin Kariko’s pioneering work -- which paved the way for the Pfizer/BioNTech and Moderna Covid-19 vaccines -- has won her the Nobel Prize in Medicine.

The Independent UK

Booking a COVID-19 vaccine? Some are reporting canceled appointments or insurance issues

Pfizer and Moderna say they have sent out millions of doses of the new COVID-19 vaccines in the past week

The Conversation

A COVID inquiry has been announced. But is COVID still a thing? Do I need a booster?

Today’s announcement of an independent inquiry into Australia’s COVID response will examine how we’ve handled the pandemic and how we could better prepare for the next one.

The Independent UK

Updated Covid vaccines from Pfizer and Moderna rolled out nationwide: Latest

An updated Coronavirus booster that targets a new variant is expected to be made available in September

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

The new Covid-19 booster shot in the US: what you need to know

US authorities have approved a vaccine that protects from one of the most widely circulating strains of coronavirus

Fortune

COVID levels are so high, they're approaching 2020's initial peak, as the WHO urges those at high risk to take any booster they can get their hands on

It’s yet another sign that while the official pandemic state may be over, the days of COVID are far from it.

Salon

CDC recommends new COVID boosters

The virus sometimes causes severe illness even in those without underlying conditions, including deaths in children

Fortune

Moderna's COVID shots will grow revenue by $8 billion this year. But the company's CFO has his eye on other targets

Moderna plans on investing $25 billion in research and development from 2024 through 2028.

The Independent UK

FDA approves updated Moderna and Pfizer Covid boosters set to arrive soon as cases rise: Latest

An updated Coronavirus booster that targets a new variant is expected to be made available in September

The Independent UK

Joe Biden sends message to Americans on Covid booster shots: ‘Stay up-to-date on vaccines’

US president’s message comes after CDC and FDA decide to recommend Covid booster shots amid rising cases

The Conversation

CDC greenlights two updated COVID-19 vaccines, but how will they fare against the latest variants? 5 questions answered

On Sept. 12, 2023, the Centers for Disease Control and Prevention recommended the newly formulated COVID-19 vaccines for all Americans ages 6 months and up, hours after its expert advisory committee voted 13 to 1 in favor of recommending the vaccines.

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

the Centers for Disease Control and Prevention

215 stories

Novavax

209 stories

the Food and Drug Administration

208 stories

BioNTech

202 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.